Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26826899)
Watch
English
Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
(English)
1 reference
stated in
PubMed
main subject
ovarian cancer
1 reference
based on heuristic
inferred from title
lead
1 reference
based on heuristic
inferred from title
neoplastic stem cells
1 reference
based on heuristic
inferred from title
author name string
Christen L Walters Haygood
series ordinal
1
1 reference
stated in
Crossref
language of work or name
English
1 reference
stated in
PubMed
publication date
26 September 2014
1 reference
stated in
PubMed
published in
World Journal of Stem Cells
1 reference
stated in
Crossref
volume
6
1 reference
stated in
PubMed
issue
4
1 reference
stated in
PubMed
page(s)
441-7
1 reference
stated in
PubMed
cites work
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
Prospective identification of tumorigenic breast cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
Epithelial-mesenchymal transitions in development and disease
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
EpCAM in carcinogenesis: the good, the bad or the ugly
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
7 April 2017
Effects and mechanisms of anti-CD44 monoclonal antibody A3D8 on proliferation and apoptosis of sphere-forming cells with stemness from human ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Colon cancer stem cells: controversies and perspectives
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Metformin targets ovarian cancer stem cells in vitro and in vivo
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Stem cell pathways contribute to clinical chemoresistance in ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD133 expression associated with poor prognosis in ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Human ovarian cancer stem cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44, a therapeutic target for metastasising tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Surgical management of recurrent ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44 and EpCAM: cancer-initiating cell markers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Wnt signaling in ovarian tumorigenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Cancer stem cell biology: from leukemia to solid tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44v6: a target for antibody-based cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
Human acute myeloid leukemia stem cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 September 2017
CD44: structure, function, and association with the malignant process.
2 references
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
31 May 2018
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer stem cell definitions and terminology: the devil is in the details.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
Expression of CD133-1 and CD133-2 in ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
Incorporation of bevacizumab in the primary treatment of ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.4252%2FWJSC.V6.I4.441
retrieved
21 January 2018
The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 November 2018
CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4172672
retrieved
28 November 2018
Cancer Stem Cells and Tumor Metastasis: First Steps into Uncharted Territory
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25258665
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25258665
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25258665
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/25258665
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.4252/WJSC.V6.I4.441
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3679492
OpenCitations bibliographic resource ID
3679492
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3679492
PMC publication ID
4172672
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3679492
PubMed publication ID
25258665
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3679492
ResearchGate publication ID
266246915
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
